Samsung Biologics ranked among the top searched stocks for 4 days in the past month.

As of 11:32 AM on the 19th, Samsung Biologics is trading at 817,000 KRW, up 1.87% from the previous day. This marks an 11.46% increase compared to July 31. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have a tentative net purchase of 4,331 shares. Over the past 5 days, individual investors have net sold 152,149 shares, while foreigners and institutions have net bought 114,925 shares and 45,187 shares, respectively.

On August 12, Samsung Biologics was a market topic for its "strong performance following the announcement of investment in the Songdo Plant 4."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing